Tarsons Products Ltd. | Small-cap | Healthcare
₹395.70
2.78%
| Tarsons Products Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.9B
Gross Profit 2.6B 67.01%
Operating Income 482.3M 12.29%
Net Income 297.7M 7.59%

Balance Sheet Metrics

Total Assets 10.8B
Total Liabilities 4.5B
Shareholders Equity 6.3B
Debt to Equity 0.71

Cash Flow Metrics

Operating Cash Flow 571.9M
Free Cash Flow -374.7M

Revenue & Profitability Trend

Tarsons Products Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.9B 2.9B 2.8B 3.0B 2.3B
Cost of Goods Sold 1.3B 942.9M 782.4M 800.6M 742.8M
Gross Profit 2.6B 2.0B 2.0B 2.2B 1.5B
Operating Expenses 868.6M 568.6M 404.8M 362.4M 265.8M
Operating Income 482.3M 633.5M 1.0B 1.3B 923.8M
Pre-tax Income 448.0M 607.7M 1.1B 1.3B 924.3M
Income Tax 150.3M 181.3M 280.1M 343.2M 235.6M
Net Income 297.7M 426.4M 807.1M 1.0B 688.7M
EPS (Diluted) - ₹8.01 ₹15.17 ₹19.46 ₹13.52

Income Statement Trend

Tarsons Products Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.4B 2.4B 2.5B 2.4B 1.1B
Non-Current Assets 8.4B 7.4B 4.7B 3.0B 1.8B
Total Assets 10.8B 9.7B 7.3B 5.4B 3.0B
Liabilities
Current Liabilities 1.8B 2.1B 629.2M 349.1M 418.0M
Non-Current Liabilities 2.7B 1.5B 934.6M 194.8M 98.1M
Total Liabilities 4.5B 3.6B 1.6B 544.0M 516.1M
Equity
Total Shareholders Equity 6.3B 6.1B 5.7B 4.9B 2.4B

Balance Sheet Composition

Tarsons Products Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 448.0M 607.7M 1.1B 1.3B 924.3M
Operating Cash Flow 571.9M 767.0M 769.5M 890.9M 783.4M
Investing Activities
Capital Expenditures -1.5B -1.8B -1.9B -1.3B -641.6M
Investing Cash Flow -1.5B -2.5B -1.8B -1.4B -641.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -13.7B 1.0B 791.9M -1.2B -1.6B
Free Cash Flow -374.7M -816.3M -1.1B -485.0M 38.3M

Cash Flow Trend

Tarsons Products Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 67.22
Forward P/E 30.30
Price to Book 3.17
Price to Sales 5.11
PEG Ratio 30.30

Profitability Ratios

Profit Margin 7.59%
Operating Margin 15.08%
Return on Equity 4.79%
Return on Assets 2.94%

Financial Health

Current Ratio 1.38
Debt to Equity 53.82
Beta 0.09

Per Share Data

EPS (TTM) ₹5.59
Book Value per Share ₹118.59
Revenue per Share ₹73.82

Financial data is updated regularly. All figures are in the company's reporting currency.